Testing effectiveness (Phase 2)Looking for participantsNCT06705023
What this trial is testing
Study to Assess Safety and Efficacy of Treating Symptomatic, Ischemic, Chronic Congestive Heart Failure Patients with an LVEF of ≤40% with Fresh, Uncultured, Autologous, Adipose-derived Regenerative Cells Isolated from Lipoaspirate.
Who this might be right for
Myocardial InjuryLV DysfunctionCoronary Artery Disease+1 more
Ralf Rothoerl 36